Characterization of zanubrutinib safety and tolerability profile and comparison with ibrutinib safety profile in patients with B-cell malignancies: post-hoc analysis of a large clinical trial safety database
Brown, Jennifer R, Ghia, Paolo, Jurczak, Wojciech, Kahl, Brad S, Lamanna, Nicole, Robak, Tadeusz, Shadman, Mazyar, Tam, Constantine S, Qiu, Lugui, Paik, Jason, Salmi, Tommi, Wang, Liping, Zhang, Jun, Zhang, Meng, Cohen, Aileen, Ma, Han, Tedeschi, Alessandra
Published in Haematologica (Roma) (29.02.2024)
Published in Haematologica (Roma) (29.02.2024)
Get full text
Journal Article
P640: ZANUBRUTINIB VS IBRUTINIB IN RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA AND SMALL LYMPHOCYTIC LYMPHOMA (R/R CLL/SLL): IMPACT ON HEALTH‐RELATED QUALITY OF LIFE (HRQOL)
Eichhorst, Barbara, Lamanna, Nicole, O’brien, Susan, Tam, Constantine, Qiu, Lugui, Yang, Keri, Wu, Ken, Salmi, Tommi, Barnes, Gisoo, Brown, Jennifer R.
Published in HemaSphere (08.08.2023)
Published in HemaSphere (08.08.2023)
Get full text
Journal Article
P631: CHARACTERIZATION OF ZANUBRUTINIB SAFETY/TOLERABILITY PROFILE AND COMPARISON WITH IBRUTINIB PROFILE IN PATIENTS WITH B‐CELL MALIGNANCIES: POST HOC ANALYSIS OF A LARGE CLINICAL TRIAL SAFETY DATABASE
Brown, Jennifer R., Eichhorst, Barbara, Ghia, Paolo, Jurczak, Wojciech, Kahl, Brad, Lamanna, Nicole, Robak, Tadeusz, Shadman, Mazyar, Tam, Constantine, Qiu, Lugui, Cohen, Aileen, Zhang, Meng, Salmi, Tommi, Paik, Jason, Wang, Liping, Zhang, Jun, MA, Han, Tedeschi, Alessandra
Published in HemaSphere (08.08.2023)
Published in HemaSphere (08.08.2023)
Get full text
Journal Article
Effect of Recombinant Zoster Vaccine on Incidence of Herpes Zoster After Autologous Stem Cell Transplantation: A Randomized Clinical Trial
Bastidas, Adriana, de la Serna, Javier, El Idrissi, Mohamed, Oostvogels, Lidia, Quittet, Philippe, López-Jiménez, Javier, Vural, Filiz, Pohlreich, David, Zuckerman, Tsila, Issa, Nicolas C, Gaidano, Gianluca, Lee, Je-Jung, Abhyankar, Sunil, Solano, Carlos, Perez de Oteyza, Jaime, Satlin, Michael J, Schwartz, Stefan, Campins, Magda, Rocci, Alberto, Vallejo Llamas, Carlos, Lee, Dong-Gun, Tan, Sen Mui, Johnston, Anna M, Grigg, Andrew, Boeckh, Michael J, Campora, Laura, Lopez-Fauqued, Marta, Heineman, Thomas C, Stadtmauer, Edward A, Sullivan, Keith M
Published in JAMA : the journal of the American Medical Association (09.07.2019)
Published in JAMA : the journal of the American Medical Association (09.07.2019)
Get full text
Journal Article
Acquired Mutations in Patients (Pts) with Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL) That Progressed in the ALPINE Study
Brown, Jennifer R., Li, Jessica, Eichhorst, Barbara F., Lamanna, Nicole, O'Brien, Susan M., Tam, Constantine S., Qiu, Luqui, Ramakrishnan, Vanitha, Huang, Ruiqi, Shi, Yang, Idoine, Adam, Salmi, Tommi, Cohen, Aileen Cleary, Shadman, Mazyar
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
Zanubrutinib Versus Ibrutinib in Relapsed/Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma: Interim Analysis of a Randomized Phase III Trial
Hillmen, Peter, Eichhorst, Barbara, Brown, Jennifer R, Lamanna, Nicole, O'Brien, Susan M, Tam, Constantine S, Qiu, Lugui, Kazmierczak, Maciej, Zhou, Keshu, Šimkovič, Martin, Mayer, Jiří, Gillespie-Twardy, Amanda, Shadman, Mazyar, Ferrajoli, Alessandra, Ganly, Peter S, Weinkove, Robert, Grosicki, Sebastian, Mital, Andrzej, Robak, Tadeusz, Österborg, Anders, Yimer, Habte A, Salmi, Tommi, Ji, Meng, Yecies, Jessica, Idoine, Adam, Wu, Kenneth, Huang, Jane, Jurczak, Wojciech
Published in Journal of clinical oncology (10.02.2023)
Published in Journal of clinical oncology (10.02.2023)
Get full text
Journal Article
ALPINE: zanubrutinib versus ibrutinib in relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma
Hillmen, Peter, Brown, Jennifer R, Eichhorst, Barbara F, Lamanna, Nicole, O'Brien, Susan M, Qiu, Lugui, Salmi, Tommi, Hilger, James, Wu, Kenneth, Cohen, Aileen, Huang, Jane, Tam, Constantine S
Published in Future oncology (London, England) (01.04.2020)
Published in Future oncology (London, England) (01.04.2020)
Get full text
Journal Article
Alpine: Phase 3 Trial of Zanubrutinib (BGB-3111) Vs Ibrutinib in Patients with Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
Hillmen, Peter, Brown, Jennifer R., Byrd, John C., Eichhorst, Barbara F., Lamanna, Nicole, O'Brien, Susan M., Qiu, Lugui, Salmi, Tommi, Hilger, James, Huang, Jane, Tam, Constantine S.
Published in Blood (13.11.2019)
Published in Blood (13.11.2019)
Get full text
Journal Article
Improved efficacy and safety of zanubrutinib versus ibrutinib in patients with relapsed/refractory chronic lymphocytic leukemia (R/R CLL) in China: a subgroup of ALPINE
Zhou, Keshu, Wang, Tingyu, Pan, Ling, Xu, Wei, Jin, Jie, Zhang, Wei, Hu, Yu, Hu, Jianda, Feng, Ru, Li, Ping, Liu, Zhougang, Liu, Peng, Jing, Hongmei, Gao, Sujun, Zhang, Huilai, Yu, Kang, Wang, Zhao, Zhu, Xiongpeng, Sun, Zimin, Li, Fei, Yan, Dongmei, Weng, Jianyu, Fu, Lina, Wang, Liping, Salmi, Tommi, Wu, Kenneth, Qiu, Lugui
Published in Annals of hematology (18.06.2024)
Published in Annals of hematology (18.06.2024)
Get full text
Journal Article
Extended Follow-up of ALPINE Randomized Phase 3 Study Confirms Sustained Superior Progression-Free Survival of Zanubrutinib Versus Ibrutinib for Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma (R/R CLL/SLL)
Brown, Jennifer R., Eichhorst, Barbara F., Lamanna, Nicole, O'Brien, Susan M., Tam, Constantine S., Qiu, Luqui, Kaźmierczak, Maciej, Jurczak, Wojciech, Zhou, Keshu, Simkovic, Martin, Mayer, Jiri, Gillespie-Twardy, Amanda L., Ferrajoli, Alessandra, Ganly, Peter S., Weinkove, Robert, Grosicki, Sebastian, Mital, Andrzej, Robak, Tadeusz, Osterborg, Anders, Yimer, Habte A., Wang, Megan (Der Yu), Salmi, Tommi, Wang, Liping, Li, Jessica, Wu, Kenneth, Cohen, Aileen Cleary, Shadman, Mazyar
Published in BLOOD (02.11.2023)
Published in BLOOD (02.11.2023)
Get full text
Journal Article
Conference Proceeding
CLL-115 First Interim Analysis of ALPINE Study: Results of a Phase 3 Randomized Study of Zanubrutinib vs Ibrutinib in Patients With Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
Brown, Jennifer R., Hillmen, Peter, Eichhorst, Barbara, Lamanna, Nicole, O'Brien, Susan, Tam, Constantine S., Qiu, Lugui, Kazmierczak, Maciej, Zhou, Keshu, Šimkovič, Martin, Mayer, Jiri, Gillespie-Twardy, Amanda, Shadman, Mazyar, Ferrajoli, Alessandra, Ganly, Peter S., Weinkove, Robert, Salmi, Tommi, Wu, Kenneth, Novotny, William, Jurczak, Wojciech
Published in Clinical lymphoma, myeloma and leukemia (01.10.2022)
Published in Clinical lymphoma, myeloma and leukemia (01.10.2022)
Get full text
Journal Article
Zanubrutinib Demonstrates Superior Progression-Free Survival (PFS) Compared with Ibrutinib for Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma (R/R CLL/SLL): Results from Final Analysis of ALPINE Randomized Phase 3 Study
Brown, Jennifer R., Eichhorst, Barbara, Hillmen, Peter, Lamanna, Nicole, O'Brien, Susan M., Tam, Constantine S., Qiu, Lugui, Kaźmierczak, Maciej, Jurczak, Wojciech, Zhou, Keshu, Šimkovič, Martin, Mayer, Jiri, Gillespie-Twardy, Amanda L., Ferrajoli, Alessandra, Ganly, Peter S., Weinkove, Robert, Grosicki, Sebastian, Mital, Andrzej, Robak, Tadeusz, Österborg, Anders, Yimer, Habte A., Salmi, Tommi, Wang, Megan (Der Yu), Fu, Lina, Li, Jessica, Wu, Kenneth, Cohen, Aileen, Shadman, Mazyar
Published in BLOOD (06.12.2022)
Published in BLOOD (06.12.2022)
Get full text
Journal Article
Conference Proceeding
Poster: CLL-115 First Interim Analysis of ALPINE Study: Results of a Phase 3 Randomized Study of Zanubrutinib vs Ibrutinib in Patients With Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
Brown, Jennifer R., Hillmen, Peter, Eichhorst, Barbara, Lamanna, Nicole, O'Brien, Susan, Tam, Constantine S., Qiu, Lugui, Kazmierczak, Maciej, Zhou, Keshu, Šimkovič, Martin, Mayer, Jiri, Gillespie-Twardy, Amanda, Shadman, Mazyar, Ferrajoli, Alessandra, Ganly, Peter S., Weinkove, Robert, Salmi, Tommi, Wu, Kenneth, Novotny, William, Jurczak, Wojciech
Published in Clinical lymphoma, myeloma and leukemia (01.10.2022)
Published in Clinical lymphoma, myeloma and leukemia (01.10.2022)
Get full text
Journal Article
Plain language summary of zanubrutinib or ibrutinib in chronic lymphocytic leukemia that is resistant to treatment or has come back after treatment
Brown, Jennifer R, Eichhorst, Barbara, Hillmen, Peter, Jurczak, Wojciech, Kaźmierczak, Maciej, Lamanna, Nicole, O'Brien, Susan M, Tam, Constantine S, Qiu, Lugui, Zhou, Keshu, Simkovic, Martin, Mayer, Jiri, Gillespie-Twardy, Amanda, Ferrajoli, Alessandra, Ganly, Peter S, Weinkove, Robert, Grosicki, Sebastian, Mital, Andrzej, Robak, Tadeusz, Osterborg, Anders, Yimer, Habte A, Salmi, Tommi, Wang, Megan-Der-Yu, Fu, Lina, Li, Jessica, Wu, Kenneth, Cohen, Aileen, Shadman, Mazyar
Published in Future oncology (London, England) (01.04.2024)
Published in Future oncology (London, England) (01.04.2024)
Get full text
Journal Article